Yuhong Liu

Dr. Yuhong Liu

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
YLYuhong Liu
Yuhong Liu
XDXiaoyong Dai
Xiaoyong Dai
SJShengwei Jiang
Shengwei Jiang
MQMulan Qahar
Mulan Qahar
CFChunyan Feng
Chunyan Feng
LHLaiqiang Huang
Laiqiang Huang
Acquired drug resistance decreases the efficacy of gefitinib after approximately 1 year of treatment in non-small-cell lung cancer (NSCLC). Autophagy is a process that could lead to cell death when it is prolonged. Thus, we investigated a drug combination therapy of gefitinib with rapamycin—a cell autophagy activator—in gefitinib-resistant NSCLC cell line H1975 to improve the therapeutic efficacy of gefitinib in advanced NSCLC cells through acute cell autophagy induction. Cell viability and tumor formation assays indicated that rapamycin is strongly synergistic with gefitinib inhibition, both in vitro and in vivo. Mechanistic studies demonstrated that EGFR expression and cell autophagy decreased under gefitinib treatment and were restored after the drug combination therapy, indicating a potential cell autophagy–EGFR positive feedback regulation. To further optimize the delivery efficiency of the combinational agents, we constructed an anti-EGFR aptamer-functionalized nanoparticle (NP-Apt) carrier system. The microscopic observation and cell proliferation assays suggested that NP-Apt achieved remarkably targeted delivery and cytotoxicity in the cancer cells. Taken together, our results suggest that combining rapamycin and gefitinib can be an efficacious therapy to overcome gefitinib resistance in NSCLC, and targeted delivery of the drugs using the aptamer-nanoparticle carrier system further enhances the therapeutic efficacy of gefitinib.

10 January 2023 in Lab on a Chip
Verified
Journal Article
Open access
PDF file
HMHiroki Matsumura
Hiroki Matsumura
LSLarina TzuWei Shen
Larina TzuWei Shen
AIAkihiro Isozaki
Akihiro Isozaki
HMHideharu Mikami
Hideharu Mikami
DYDan Yuan
Dan Yuan
SMSatoshi Matsusaka
Satoshi Matsusaka
Heterogeneous clusters of cancer cells and leukocytes in blood were visualized by combining high-throughput and high-sensitivity fluorescence imaging flow cytometry with 5-aminolevulinic acid stimulation.

21 October 2025 in Journal of Extracellular Biology
Verified
Journal Article
Open access
YLYuhong Liu
Yuhong Liu
NINatsumi Tiffany Ishii
Natsumi Tiffany Ishii
JDJun‐Yu Dong
Jun‐Yu Dong
YZYaqi Zhao
Yaqi Zhao
YLYingdong Luo
Yingdong Luo
KGKeisuke Goda
Keisuke Goda
Small extracellular vesicles (sEVs), ranging from 30 to 200 nm in diameter, are a subset of extracellular vesicles that play an essential role in intercellular communication by transporting bioactive molecules between cells. Due to their diverse cargo and origins, sEVs form a highly heterogeneous population. Previous studies have suggested that recipient cells uptake specific sEVs to ensure accurate signalling, but direct experimental evidence on how cells effectively communicate in such a complex and noisy environment has been lacking. In this study, we provide direct experimental evidence by developing a method to retrieve and analyze internalized sEVs from the intracellular membrane compartments of recipient cells. Using this sEV retrieval method, we isolated sEV subpopulations from two types of breast cancer cells after incubation with sEVs derived from mixed cell cultures. We then assessed their functional roles by evaluating the phenotypic responses of cells treated with these retrieved sEV subpopulations. Our results reveal apparent differences in their functional impacts, indicating that cells employ a function‐based mechanism to selectively uptake sEVs. This finding advances our understanding of how cells enhance communication efficiency via sEVs. Further investigation into this phenomenon could offer deeper insights into intercellular communication and its role in health and disease.

22 July 2026 in Nature Biomedical Engineering
Verified
Journal Article
Open access
HWHuai-Song Wang
Huai-Song Wang
TDTianben Ding
Tianben Ding
YLYuhong Liu
Yuhong Liu
FLFabio Lisi
Fabio Lisi
YZYuqi Zhou
Yuqi Zhou
KGKeisuke Goda
Keisuke Goda
Homotypic targeting is the inherent ability of cells to preferentially interact with cells of the same type, a phenomenon seen in cell adhesion, tissue formation and immune responses. However, its potential remains underexploited. Here we report a strategy to substantially enhance homotypic targeting through extracellular vesicles secreted by cells. By engineering the surface of small extracellular vesicles (sEVs) with lanthanides, we amplify specific cell–sEV interactions by more than 25-fold, enabling the selective capture of sEVs by cells of the same lineage even in the presence of excess off-target sEVs. We term this effect ‘super homotypic targeting’. Super homotypic targeting provides a means to distinguish sEVs of different origins within highly heterogeneous sEV populations and enables two applications: using cells to detect specific sEVs and using sEVs to detect specific cells, specifically demonstrated here in the context of cancer detection from blood samples. Super homotypic targeting could hold potential for diagnostics, immunotherapy, drug delivery, rejuvenation and tissue engineering.

20 October 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
YLYingdong Luo
Yingdong Luo
TDTianben Ding
Tianben Ding
YLYuhong Liu
Yuhong Liu
YZYaqi Zhao
Yaqi Zhao
HWHanqing Wang
Hanqing Wang
KGKeisuke Goda
Keisuke Goda
Organelle architecture is a key determinant of cellular state. However, its heterogeneity remains difficult to quantify at population scale because conventional imaging flow cytometry is diffraction-limited. Here we present super-resolution imaging flow cytometry (SR-IFC), a high-throughput structured-illumination platform combining stroboscopic excitation, microfluidic hydrodynamic focusing and AI-assisted reconstruction. From three phase-shifted frames acquired along the flow axis, SR-IFC reconstructs images with approximately 118-nm isotropic in-plane resolution, about two-fold beyond the diffraction limit, at up to approximately 720 cells per second. In microbiology, SR-IFC resolves individual lipid droplets in nitrogen-starved Euglena gracilis and reveals spatial reorganization during lipid biogenesis missed by diffraction-limited imaging. In immunology, it maps activation-associated mitochondrial remodeling across primary human CD8 + T-cell differentiation, including a transient networked state. SR-IFC thus provides a broadly applicable platform for population-scale super-resolution phenotyping across diverse areas of biology.